Literature DB >> 36169897

Claudin-6 increases SNAI1, NANOG and SOX2 gene expression in human gastric adenocarcinoma AGS cells.

Priscila Anhel Medrano-Gonzálezl1, Franklin Cruz-Villegas1, Alejandro Alarcón Del Carmen1, Luis Felipe Montaño1, Erika Patricia Rendón-Huerta2.   

Abstract

BACKGROUND: Gastric cancer is a heterogeneous disease associated to deregulated gastric epithelia tight junction barrier function and di novo expression of claudin-6; these changes are associated with epithelial-mesenchymal transition, enhanced invasiveness, metastatic progression, resistance to chemotherapy, and poor prognosis. Gastric cancer stem cells represent a rare population of cells within the tumor implicated in tumor growth and higher tumorigenic capacity. The possible relation between claudin-6 expression and the expression of some markers associated to epithelial mesenchymal transition and cancer stem cells in gastric cancer cells have never been explored. METHODS AND
RESULTS: CD44, CD24, Twist, Villin, DCLK1, claudin-6, NANOG, E-Cadherin, SOX2, and SNAI1 expression was evaluated by immunofluorescence and cytofluorometry in wild type and Claudin-6 transfected AGS cells. Cell migration assays were also performed. Differentially expressed genes and biological processes analysis was performed to determine gene preponderance. The results showed that claudin-6 overexpression enriched the CD44 + /CD24- subpopulation with an overall increase in the expression and the number of CD44 + cells. A significant increase in NANOG, SOX2 and SNAI1 expression and enhanced cell migration was observed in claudin-6 transfected cells. Transcriptome analysis revealed 271 genes involved in enhanced biological processes with only 31 with a significantly p value; thirteen of those genes are closely associated to epithelial mesenchymal transition processes and folding and unfolding processes of proteins in the endoplasmic reticulum.
CONCLUSIONS: The pro-tumorigenic effect of claudin-6 in gastric cancer could be associated to dedifferentiation of epithelial cells and an increase in di novo cancer stem cell genesis.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  CD44; Cancer stem cell; Claudin 6; Gastric cancer; Tight junctions

Year:  2022        PMID: 36169897     DOI: 10.1007/s11033-022-07976-z

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.742


  54 in total

1.  Model for the architecture of claudin-based paracellular ion channels through tight junctions.

Authors:  Hiroshi Suzuki; Kazutoshi Tani; Atsushi Tamura; Sachiko Tsukita; Yoshinori Fujiyoshi
Journal:  J Mol Biol       Date:  2014-11-04       Impact factor: 5.469

2.  The expression patterns of tight junction protein claudin-1, -3, and -4 in human gastric neoplasms and adjacent non-neoplastic tissues.

Authors:  Haiming Wang; Xingwang Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

3.  The expression of claudin-1, claudin-2, claudin-3, and claudin-4 in gastric cancer tissue.

Authors:  Hun Jung; Kyong Hwa Jun; Ji Han Jung; Hyung Min Chin; Woo Bae Park
Journal:  J Surg Res       Date:  2010-03-06       Impact factor: 2.192

4.  Tight Junction-Related CLDN5 and CLDN6 Genes, and Gap Junction-Related GJB6 and GJB7 Genes Are Somatically Mutated in Gastric and Colorectal Cancers.

Authors:  Hyun Ji Son; Chang Hyeok An; Nam Jin Yoo; Sug Hyung Lee
Journal:  Pathol Oncol Res       Date:  2020-03-13       Impact factor: 3.201

5.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

6.  Claudin-4 expression in gastric cancer cells enhances the invasion and is associated with the increased level of matrix metalloproteinase-2 and -9 expression.

Authors:  Tsann-Long Hwang; Tzu-Tsung Changchien; Chee-Chan Wang; Chi-Ming Wu
Journal:  Oncol Lett       Date:  2014-06-27       Impact factor: 2.967

7.  Characterization of the first-in-class T-cell-engaging bispecific single-chain antibody for targeted immunotherapy of solid tumors expressing the oncofetal protein claudin 6.

Authors:  Christiane R Stadler; Hayat Bähr-Mahmud; Laura M Plum; Kathrin Schmoldt; Anne C Kölsch; Özlem Türeci; Ugur Sahin
Journal:  Oncoimmunology       Date:  2015-10-29       Impact factor: 8.110

8.  Claudin3 is localized outside the tight junctions in human carcinomas.

Authors:  Chiara Romani; Stefania Mitola; Michela Corsini; Antonella Ravaggi; Franco Odicino; Alessandro Davide Santin; Cosetta Ravelli; Marco Presta
Journal:  Oncotarget       Date:  2018-04-06

9.  HDAC-4 regulates claudin-2 expression in EGFR-ERK1/2 dependent manner to regulate colonic epithelial cell differentiation.

Authors:  Rizwan Ahmad; Balawant Kumar; Kaichao Pan; Punita Dhawan; Amar B Singh
Journal:  Oncotarget       Date:  2017-09-23

Review 10.  Tumor heterogeneity of gastric cancer: From the perspective of tumor-initiating cell.

Authors:  Jian-Peng Gao; Wei Xu; Wen-Tao Liu; Min Yan; Zheng-Gang Zhu
Journal:  World J Gastroenterol       Date:  2018-06-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.